Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
Raffi, Francois, Prof, Rachlis, Anita, Prof, Stellbrink, Hans-Jürgen, Prof, Hardy, W David, MD, Torti, Carlo, MD, Orkin, Chloe, MD, Bloch, Mark, MD, Podzamczer, Daniel, MD, Pokrovsky, Vadim, Prof, Pulido, Federico, MD, Almond, Steve, MMath, Margolis, David, MD, Brennan, Clare, DPT, Min, Sherene, MD
Published in The Lancet (British edition) (02.03.2013)
Published in The Lancet (British edition) (02.03.2013)
Get full text
Journal Article
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
Sax, Paul E, Dr Prof, Wohl, David, MD, Yin, Michael T, Prof, Post, Frank, MD, DeJesus, Edwin, MD, Saag, Michael, MD, Pozniak, Anton, MD, Thompson, Melanie, MD, Podzamczer, Daniel, MD, Molina, Jean Michel, Prof, Oka, Shinichi, MD, Koenig, Ellen, MD, Trottier, Benoit, MD, Andrade-Villanueva, Jaime, MD, Crofoot, Gordon, MD, Custodio, Joseph M, PharmD, Plummer, Andrew, MS, Zhong, Lijie, PhD, Cao, Huyen, MD, Martin, Hal, MD, Callebaut, Christian, PhD, Cheng, Andrew K, MD, Fordyce, Marshall W, MD, McCallister, Scott, MD
Published in The Lancet (British edition) (27.06.2015)
Published in The Lancet (British edition) (27.06.2015)
Get full text
Journal Article
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
Arribas, José R, Dr, Girard, Pierre-Marie, MD, Landman, Roland, MD, Pich, Judit, PharmD, Mallolas, Josep, MD, Martínez-Rebollar, María, MD, Zamora, Francisco X, MD, Estrada, Vicente, MD, Crespo, Manuel, MD, Podzamczer, Daniel, MD, Portilla, Joaquín, MD, Dronda, Fernando, MD, Iribarren, José A, MD, Domingo, Pere, MD, Pulido, Federico, MD, Montero, Marta, MD, Knobel, Hernando, MD, Cabié, André, Prof, Weiss, Laurence, Prof, Gatell, José M, Prof
Published in The Lancet infectious diseases (01.07.2015)
Published in The Lancet infectious diseases (01.07.2015)
Get full text
Journal Article
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
Orkin, Chloe, DeJesus, Edwin, Ramgopal, Moti, Crofoot, Gordon, Ruane, Peter, LaMarca, Anthony, Mills, Anthony, Vandercam, Bernard, de Wet, Joseph, Rockstroh, Jürgen, Lazzarin, Adriano, Rijnders, Bart, Podzamczer, Daniel, Thalme, Anders, Stoeckle, Marcel, Porter, Danielle, Liu, Hui C, Cheng, Andrew, Quirk, Erin, SenGupta, Devi, Cao, Huyen
Published in The lancet HIV (01.05.2017)
Published in The lancet HIV (01.05.2017)
Get more information
Journal Article
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial
Pollard, Richard B, MD, Rockstroh, Jürgen K, MD, Pantaleo, Giuseppe, MD, Asmuth, David M, MD, Peters, Barry, MD, Lazzarin, Adriano, Prof, Garcia, Felipe, MD, Ellefsen, Kim, MSc, Podzamczer, Daniel, MD, van Lunzen, Jan, MD, Arastéh, Keikawus, MD, Schürmann, Dirk, MD, Clotet, Bonaventura, MD, Hardy, W David, MD, Mitsuyasu, Ronald, MD, Moyle, Graeme, MD, Plettenberg, Andreas, MD, Fisher, Martin, MD, Fätkenheuer, Gerd, MD, Fischl, Margaret, MD, Taiwo, Babafemi, MD, Baksaas, Ingebjørg, PhD, Jolliffe, Darren, MSc, Persson, Stefan, PhD, Jelmert, Øyvind, MSc, Hovden, Arnt-Ove, PhD, Sommerfelt, Maja A, PhD, Wendel-Hansen, Vidar, Dr, Sørensen, Birger, MSc
Published in The Lancet infectious diseases (01.04.2014)
Published in The Lancet infectious diseases (01.04.2014)
Get full text
Journal Article